BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 21, 2025
Home » Topics » Financings

Financings
Financings RSS Feed RSS

DNA illustration

No drama as Horama raises $25M, becomes Coave Therapeutics to reflect wider focus

July 21, 2021
By Cormac Sheridan
DUBLIN – Coave Therapeutics unveiled a new identity and a new gene therapy platform, as it closed a €21.2 million (US$25 million) extension to its long-running series B round, which takes the total raise to €33 million.
Read More

Financings for July 21, 2021

July 21, 2021
Med-tech firms raising money in public or private financings, including: Arcscan, Biospectal, Motus GI, Spectral Medical, Woebot.
Read More

Vedanta’s $68M series D to bolster its human microbiome therapies

July 21, 2021
By Lee Landenberger
Proceeds from Vedanta Biosciences Inc.’s just closed $68 million series D financing will be used for a phase III study of the company’s lead candidate, VE-303, composed of eight clonal human commensal bacterial strains to give colonization resistance for treating Clostridioides difficile (C. diff) infection, and also for a phase II study of VE-202, made up of 16 clonal human commensal bacterial strains for treating inflammatory bowel disease.
Read More

BIO Asia-Taiwan 2021 looks at financing strategies booming market

July 21, 2021
By Doris Yu
Financing is the fuel that drives growth in the biopharma sector, and participants at the BIO Asia-Taiwan Conference 2021 this week discussed different financing strategies for companies in the currently booming market.
Read More

Financings for July 21, 2021

July 21, 2021
Biopharmas raising money in public or private financings, including: Clexbio, Cytokinetics, Erasca, Imago, Immutep, Reform, Regencell, Surface, Turnstone.
Read More

Biocytogen forms partnership and closes new financing round

July 20, 2021
By Doris Yu
Having created a profitable preclinical services business, Biocytogen Pharmaceuticals Co. Ltd. is now working to develop its own pipeline of antibody therapeutics, recently inking a partnership with China Resources Biopharmaceutical Co. Ltd. to develop drugs for oncology and immunology indications and raising “tens of millions of dollars” in a new financing round to support the development of its antibody drugs.
Read More

Financings for July 20, 2021

July 20, 2021
Biopharmas in Asia-Pacific raising money in public or private financings, including: Adlai Nortye, Alpha, Aslan, Grit, Insilico Medicine, Regencell, Sareum, Wugen.
Read More
European investing illustration

Panakès Partners banks $177M at first close of second fund

July 20, 2021
By Cormac Sheridan
DUBLIN – Panakès Partners SGR SpA has raised €150 million (US$177 million) in a first close of its second fund and is looking to secure a final tally of €180 million by year-end. That would represent more than twice the size of its first fund of €80 million and reflects its move into therapeutics investing.
Read More

Financings for July 20, 2021

July 20, 2021
Med-tech firms raising money in public or private financings, including: Eyenuk, Ortho Regenerative Technologies, Sight Sciences.
Read More

Rivus raises $35M to pursue mitochondrial uncoupling for cardiometabolic disease

July 20, 2021
By Cormac Sheridan
Rivus Pharmaceuticals Inc. has emerged from stealth and disclosed a $35 million series A round to fund development of its pipeline of “controlled metabolic accelerators,” or CMAs, for treating cardiometabolic diseases.
Read More
Previous 1 2 … 370 371 372 373 374 375 376 377 378 … 580 581 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 21, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 21, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 20, 2025
  • Drug capsule and dollar sign

    Little bite from voluntary most-favored nation Rx pricing order

    BioWorld
    After a week of hype, the most-favored nation (MFN) drug pricing executive order (EO) U.S. President Donald Trump signed May 12 has a lot of bark but little bite,...
  • Illustration of liver with DNA double helixes

    ASGCT 2025: Gene and cell therapies transform metabolic diseases

    BioWorld Science
    Metabolic disorders such as argininosuccinic and glutaric aciduria, methylmalonic acidemia, homocystinuria or primary hyperoxaluria require specific diets to...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing